Causal Assessment of Pharmaceutical Treatments: Why Standards of Evidence Should not be the Same for Benefits and Harms?
Crossref DOI link: https://doi.org/10.1007/s40264-014-0249-5
Published Online: 2014-12-18
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Osimani, Barbara
Mignini, Fiorenzo
Text and Data Mining valid from 2014-12-18